Back
IDEAYA Biosciences 10K Form
Sell
17
IDYA
IDEAYA Biosciences
Last Price:
$25.20
Seasonality Move:
-5.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IDYA News And Ratings
See the #1 stock for the next 7 days that we like better than IDYA
IDYA Financial Statistics
Sales & Book Value
Annual Sales: | $23.4M |
---|---|
Cash Flow: | $-49.7M |
Price / Cash Flow: | 0 |
Annual Sales: | $13.67 |
Price / Book: | 1.84 |
Profitability
EPS (TTM): | -2.33000 |
---|---|
Net Income (TTM): | $-179.6M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
IDEAYA Biosciences Earnings Forecast
Key IDEAYA Biosciences Financial Ratios
-
The Research & Development expenses have been 553.81% of Revenue.
-
The Net Earning history of IDYA is -483.05% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 1 years.
IDEAYA Biosciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | IDYA |
CUSIP: | 45166A |
Website: | ideayabio.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
IDYA Technical Analysis vs Fundamental Analysis
Sell
17
IDEAYA Biosciences (IDYA)
is a Sell
Is IDEAYA Biosciences a Buy or a Sell?
-
IDEAYA Biosciences stock is rated a SellThe current IDEAYA Biosciences [IDYA] share price is $25.16. The Score for IDYA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.